Jubilant Biosys is a contract research organization that provides comprehensive Drug Discovery Services and Contract Research services in partnership with leading worldwide pharmaceutical and healthcare companies.

Jubilant Biosys Ltd (JBL) offers services in Structural Biology, Computational Chemistry, Medicinal Chemistry, in-vitro and in-vivo Biology, DMPK and Toxicology areas to various pharmaceutical and biotechnology. Jubilant Biosys Limited (JBL) is a subsidiary of Jubilant Life Sciences (a $1.3 Bn Sales Corporation) providing innovative drug discovery services to the global life sciences, agrochemicals and specialty chemicals industry through its research centers in India. Jubilant's services in discovery research include; Jubilant's services in discovery research includes; • Target Identification/Target Validation to Lead Optimization/ Preclinical candidate, for multiple therapeutic areas viz; Oncology, Metabolic Disorders, CNS, Pain, Inflammation, Fibrosis and Respiratory diseases. • Functional services comprising of computational chemistry/ molecular modeling, medicinal chemistry, synthetic chemistry, scale-up (Non-GMP & GMP), structural biology, ADME-PK,in-vitro and in-vivo biology and IND enabling GLP toxicology.

Drug researchers often only have ten years or fewer of patent exclusivity on branded medications once they reach the market because the full drug development process typically takes between ten and fifteen years from beginning to end.